Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry.
Obach V, Velasco F, Alvarez Escudero R, Martín Bujanda M, Aranceta S, Fabregat N, Marco T, Ruisanchez A, Roncero N, Mínguez-Olaondo A, Ruibal M, Guisado-Alonso D, Moreira A, Cuadrado-Godia E, Echeverria A, Kortazar Zubizarreta I, López-Bravo A, Riesco N, González-Fernández L, Pola N, Manera P, Guerrero-Peral ÁL, Oterino Duran A, González-Osorio Y, Armand R, Fernández-Fernández S, García-Azorín D, García-Moncó JC. Obach V, et al. Among authors: guerrero peral al. J Headache Pain. 2023 Nov 22;24(1):157. doi: 10.1186/s10194-023-01690-2. J Headache Pain. 2023. PMID: 37993795 Free PMC article.
Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
Fernández-de-Las-Peñas C, Rodríguez-Jiménez J, Cancela-Cilleruelo I, Guerrero-Peral A, Martín-Guerrero JD, García-Azorín D, Cornejo-Mazzuchelli A, Hernández-Barrera V, Pellicer-Valero OJ. Fernández-de-Las-Peñas C, et al. JAMA Netw Open. 2022 Nov 1;5(11):e2242106. doi: 10.1001/jamanetworkopen.2022.42106. JAMA Netw Open. 2022. PMID: 36378309 Free PMC article.
Increased MRI-based Brain Age in chronic migraine patients.
Navarro-González R, García-Azorín D, Guerrero-Peral ÁL, Planchuelo-Gómez Á, Aja-Fernández S, de Luis-García R. Navarro-González R, et al. J Headache Pain. 2023 Oct 6;24(1):133. doi: 10.1186/s10194-023-01670-6. J Headache Pain. 2023. PMID: 37798720 Free PMC article.
Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study.
Gonzalez-Martinez A, Sanz-García A, García-Azorín D, Rodríguez-Vico J, Jaimes A, Gómez García A, Casas-Limón J, Díaz de Terán J, Sastre-Real M, Membrilla J, Latorre G, Calle de Miguel C, Gil Luque S, Trevino-Peinado C, Quintas S, Heredia P, Echavarría-Íñiguez A, Guerrero-Peral Á, Sierra Á, González-García N, Porta-Etessam J, Gago-Veiga AB. Gonzalez-Martinez A, et al. Pain Med. 2024 Mar 1;25(3):194-202. doi: 10.1093/pm/pnad141. Pain Med. 2024. PMID: 37847661
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.
Caronna E, Gallardo VJ, Egeo G, Vázquez MM, Castellanos CN, Membrilla JA, Vaghi G, Rodríguez-Montolio J, Fabregat Fabra N, Sánchez-Caballero F, Jaimes Sánchez A, Muñoz-Vendrell A, Oliveira R, Gárate G, González-Osorio Y, Guisado-Alonso D, Ornello R, Thunstedt C, Fernández-Lázaro I, Torres-Ferrús M, Alpuente A, Torelli P, Aurilia C, Pére RL, Castrillo MJR, Icco R, Sances G, Broadhurst S, Ong HC, García AG, Campoy S, Sanahuja J, Cabral G, Beltrán Blasco I, Waliszewska-Prosół M, Pereira L, Layos-Romero A, Luzeiro I, Dorado L, Álvarez Escudero MR, May A, López-Bravo A, Martins IP, Sundal C, Irimia P, Lozano Ros A, Gago-Veiga AB, Juanes FV, Ruscheweyh R, Sacco S, Cuadrado-Godia E, García-Azorín D, Pascual J, Gil-Gouveia R, Huerta-Villanueva M, Rodriguez-Vico J, Viguera Romero J, Obach V, Santos-Lasaosa S, Ghadiri-Sani M, Tassorelli C, Díaz-de-Terán J, Díaz Insa S, Oria CG, Barbanti P, Pozo-Rosich P; EUREkA study group. Caronna E, et al. J Neurol Neurosurg Psychiatry. 2024 Sep 17;95(10):927-937. doi: 10.1136/jnnp-2023-333295. J Neurol Neurosurg Psychiatry. 2024. PMID: 38777579
Consensus recommendations for the treatment of migraine prevention.
Calleja-Hernández MÁ, Guerrero-Peral ÁL, Irimia-Sieira P, Martínez-López I, Santos-Lasaosa S, Sarobe-Carricas M, López-Matencio JMS, Láinez-Andrés JM. Calleja-Hernández MÁ, et al. Farm Hosp. 2023 Nov-Dec;47(6):246-253. doi: 10.1016/j.farma.2023.03.011. Epub 2023 Jun 14. Farm Hosp. 2023. PMID: 37321919 Free article. English, Spanish.
[Translated article] Consensus recommendations on the preventive treatment of migraine.
Calleja-Hernández MÁ, Guerrero-Peral ÁL, Irimia-Sieira P, Martínez-López I, Santos-Lasaosa S, Sarobe-Carricas M, López-Matencio JMS, Láinez-Andrés JM. Calleja-Hernández MÁ, et al. Farm Hosp. 2023 Nov-Dec;47(6):T246-T253. doi: 10.1016/j.farma.2023.07.002. Epub 2023 Sep 18. Farm Hosp. 2023. PMID: 37730507 Free article. English, Spanish.
Persistent headache after COVID-19: Pathophysioloy, clinic and treatment.
Membrilla JA, Caronna E, Trigo-López J, González-Martínez A, Layos-Romero A, Pozo-Rosich P, Guerrero-Peral Á, Gago-Veiga AB, Andrés-López A, Díaz de Terán J. Membrilla JA, et al. Neurol Perspect. 2021 Dec;1:S31-S36. doi: 10.1016/j.neurop.2021.10.003. Epub 2021 Dec 14. Neurol Perspect. 2021. PMID: 38620971 Free PMC article. Review.
Improved comprehension of influenza-related headaches: Perspectives and suggestions for incidence and prevalence of headache in influenza-Response.
García-Azorín D, Santana-López L, Ordax-Díez A, Lozano-Alonso JE, Macias Saint-Gerons D, González-Osorio Y, Rojo-Rello S, Eiros JM, Sánchez-Martínez J, Sierra-Mencía Á, Recio-García A, Guerrero-Peral ÁL, Sanz-Muñoz I. García-Azorín D, et al. Among authors: guerrero peral al. Eur J Neurol. 2024 Dec;31(12):e16478. doi: 10.1111/ene.16478. Epub 2024 Sep 30. Eur J Neurol. 2024. PMID: 39344690 Free PMC article. No abstract available.
114 results